# Anavex Life Sciences Corp.: Form 8-K, filed Mar 13, 2023

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: 8-K
- Filed: 2023-03-13
- Accepted by EDGAR: Mar 10, 2023, 18:32 ET
- Period: 2023-03-10
- Accession: 0001731122-23-000348
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112223000348/e4486_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112223000348/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112223000348/e4486_8-k.htm

Filed Mar 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001731122-23-000348. Last ingested by Listed: Nov 6, 2026, 20:17 ET. No prices; not investment advice.